{"text": "commented on adct gild dskyf bristol s up to 3b deal with eisai puts antibody drug conjugates in the spotlight"}
{"text": "helpful review of eha 2021 presentations by cris autl mbio gild kite grcl cris an aml patient w an sgf3b1 mut had a durable objective response for 8 months had a complete remission amp subsequently achieved negative minimal residual disease"}
{"text": "gild bullish reversal at support level s1 at resistance level e50 1 minute 15 59"}
{"text": "gild"}
{"text": "gild bearish reversal at resistance level e50 1 minute 15 57"}
{"text": "big volume coming in on gild"}
